Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 165 recruiting studies, sorted by proximity — each links to its official registry page
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Abbott Medical Devices
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Tricuspid Regurgitation
N/A
Observational 800 participants sought
Ascension Via Christi — Wichita, Kansas (0.4 mi)
· Sponsor: Montefiore Medical Center
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 155 participants sought
Cancer Center of Kansas, Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: TORL Biotherapeutics, LLC
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: SWOG Cancer Research Network
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Heartland Research Associates, LLC - An AMR Company — Wichita, Kansas (0.4 mi)
· Sponsor: TriGemX Bio, Inc.
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Obesity, Overweight
Phase 3
Interventional 950 participants sought
Alliance for Multispecialty Research LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Amgen
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Ferring Pharmaceuticals
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
Vaginal Dysbiosis
Phase 2
Interventional 30 participants sought
Cypress Medical Research Centre — Wichita, Kansas (0.4 mi)
· Sponsor: Freya Biosciences ApS
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Weight Management
Phase 3
Interventional 4,500 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Robert J Dole VA Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Robert J Dole VA Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Wesley Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Symptomatic Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
NextStage Clinical Research, St. Francis Medical Park — Wichita, Kansas (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Wichita Nephrology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
IDC Clinical Research, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Vedanta Biosciences, Inc.
Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study
Urolithiasis, Stones, Kidney
N/A
Observational 1,000 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Calyxo, Inc.
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Kansas Nephrology Physicians, PA — Wichita, Kansas (0.4 mi)
· Sponsor: CSL Behring
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
PCOM2 - The Physician Communication Intervention, Version 2.0
HPV Infection, Preventive Health Services
N/A
Interventional 120 participants sought
University of Kansas Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: University of Colorado, Denver
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Coronary Artery Disease
N/A
Interventional 150 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Teleflex
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Relay Therapeutics, Inc.
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Wichita, Kansas (0.4 mi)
· Sponsor: Alnylam Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
AMR Wichita East, KS (Heartland Research Associates) — Wichita, Kansas (0.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated